Previous 10 | Next 10 |
Aethlon Medical, Inc. (AEMD) Q1 2021 Earnings Conference Call Aug 9, 2021 4:30 PM ET Company Participants Chuck Fisher - Chief Executive Officer and Director Jim Frakes - Chief Financial Officer and Senior Vice President Conference Call Participants Jeremy Pearlman - Maxim group Vernon Bernar...
Aethlon Medical (NASDAQ:AEMD): Q1 GAAP EPS of -$0.16 misses by $0.03. Revenue of $0.13M (-99.2% Y/Y) misses by $0.04M. At June 30, 2021, Aethlon Medical had a cash balance of approximately $25.2 million. Shares -0.57%. Press Release For further details see: Aethlon Medical EPS misses by...
Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 9, 2021 PR Newswire SAN DIEGO , July 29, 2021 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet needs in gl...
Why is the stock market down today? That’s one of the questions being asked by countless investors today. Whether we’re talking about penny stocks or blue-chips, the trend has shaken investors. Why Are Stocks Down Today? The Dow & the S&P 500 continued to drop ...
Gainers: Rx Pharmaceuticals (NRXP) +73%.Cytokinetics, (CYTK) +40%.Aehr Test Systems (AEHR) +29%.Allied Healthcare Products (AHPI) +27%.Mer Telemanagement Solutions (MTSL) +26%.SPX FLOW (FLOW) +22%.Alpha Pro Tech (APT) +23%.Alfi (ALF) +21%.Nuwellis (NUWE) +19%.Aethlon Medical (AEMD) +16%.Loser...
Gainers: Freeline Therapeutics (FRLN) +88%, Cytokinetics CYTK +49%, NRx Pharmaceuticals NRXP +37%, Allied Healthcare Products (AHPI) +19%, Aethlon Medical (AEMD) +16%.Losers: China SXT Pharmaceuticals (SXTC) -21%, Atossa Therapeutics (ATOS)...
Tempest Therapeutics (TPST) +141%.Mer Telemanagement Solutions (MTSL) +56%.Celldex Therapeutics (CLDX) +41% on early-stage data for CDX-0159 in skin condition.SGOCO Group (SGOC) +38%.Antelope Enterprise Holdings (AEHL) +30%.Cemtrex (CETX) +19%.Carver Bancorp (CARV) +15%.Park City Gr...
Aethlon Medical (AEMD): FY GAAP EPS of -$0.65 beats by $0.05.Revenue of $0.66M (+1.5% Y/Y) misses by $0.33M.Shares -0.75%.Press Release For further details see: Aethlon Medical EPS beats by $0.05, misses on revenue
Aethlon Medical to Release Fourth Quarter Financial Results and Host Conference Call on June 24, 2021 PR Newswire SAN DIEGO , June 21, 2021 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical device technology company focused on unmet nee...
Gainers: Opthea (OPT) +47%, Kindred Biosciences (KIN) +45%, Aprea Therapeutics (APRE) +38%, Altimmune (ALT) +21%, BriaCell Therapeutics (BCTX) +15%.Losers: Inhibikase Therapeutics (IKT) -24%, Paratek Pharmaceuticals (PRTK) -14%,...
News, Short Squeeze, Breakout and More Instantly...
2024-06-28 12:40:00 ET SAN DIEGO - June 28, 2024 (Investorideas.com Newswire) Aethlon Medical, Inc. ( Nasdaq: AEMD ), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today reported financial results for its fiscal ye...
Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update PR Newswire Conference Call to be Held Today at 4:30 p.m. ET SAN DIEGO , June 27, 2024 /PRNewswire/ -- Aethlon Medical, Inc. (Na...
DS Smith Plc. (DITHF) is expected to report for Q4 2024 Bluegreen Vacations Holding Corporation - Class B (BVHBB) is expected to report for Q1 2024 Harbour Energy Plc ADR (HBRIY) is expected to report for Q1 2024 Bayerische Motoren Werke AG (BAMXF) is expected to report for Q1 2024 ...